Browse by author
Lookup NU author(s): Dr Fiona Jenkinson
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© 2025 The AuthorsPurpose: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder. This study aimed to analyze the genotype distribution of FCS-causing genes in the United Kingdom. Methods: Data were anonymously collated from 2 genetic testing laboratories providing national genetic diagnosis services for severe hypertriglyceridemia in the United Kingdom. Results: As of December 2023, 880 individuals underwent genetic testing for FCS. The mean (SD) age at the time of genetic testing was 42.5 (15.3) years. After genotyping, 12.9% of the individuals (n = 114) received a genetic diagnosis of FCS. The detection rate of variant-positive multifactorial chylomicronemia syndrome, ie, heterozygous for pathogenic/likely pathogenic (P/LP) variants in 1 of the 5 canonical genes was 11.4% (n = 100). Among 114 genetically proven FCS individuals, 52.6% (n = 60) had biallelic P/LP LPL variants (ie, LPL-FCS), 45.6% (n = 52) had biallelic non-LPL P/LP variants (ie, non-LPL-FCS) and 1.7% (n = 2) individuals were digenic. Among non-LPL-FCS (n = 52), the most common gene implicated was GPIHBP1 (42.3%, n = 22), followed by APOA5 (32.7%, n = 17), LMF1 (13.5%, n = 7) and APOC2 (11.5%, n = 6). Most variant-positive multifactorial chylomicronemia syndrome harbored P/LP variants in LPL (61%) or APOA5 (37%). The geographical distribution of FCS demonstrated regional variability, where the Northwest of England had the highest number of FCS cases per million population. Individuals of European geographic ancestry predominantly had LPL-FCS (60.9%); however, genotype was more diverse in individuals of non-European origin (LPL 47.1%, GPIHBP1 30.9%, APOA5 8.8%, LMF1 7.4%, and APOC2 4.4%). Variants in specific causal genes, GPIHBP1 and LMF1, were predominantly observed in non-European FCS individuals. Conclusion: The genetic architecture of FCS in the United Kingdom is complex, with a substantial proportion affected by non-LPL FCS-causing genes. It also displays a significant regional and ethnic variations.
Author(s): Bashir B, Forrester N, Downie P, Marsh S, Dent C, Wierzbicki AS, Dawson C, Schofield J, Jenkinson F, Mansfield M, Datta D, Delaney H, Teoh Y, Hamilton P, Cegla J, Ferdousi M, Kamath A, Gupta P, Luvai A, O'Sullivan D, Mamood D, Wang J, Durrington PN, Hegele RA, Soran H
Publication type: Article
Publication status: Published
Journal: Genetics in Medicine Open
Year: 2025
Volume: 3
Online publication date: 14/07/2025
Acceptance date: 08/07/2025
Date deposited: 02/09/2025
ISSN (electronic): 2949-7744
Publisher: Elsevier B.V.
URL: https://doi.org/10.1016/j.gimo.2025.103445
DOI: 10.1016/j.gimo.2025.103445
Data Access Statement: The data that support the findings of this study are available from the corresponding author upon request.
Altmetrics provided by Altmetric
